Keyword: Lovenox

Riival generics makers are squashing long-running lawsuits over their own versions of Sanofi's big-selling blood thinner Lovenox.

A long patent battle against Momenta and Sandoz has ended in Amphastar’s favor, freeing the small drugmaker from the threat of almost $1B in damages.

The FDA has approved Portola Pharmaceuticals’ factor Xa inhibitor Bevyxxa, but now the company is facing plenty of challenges as it gets the drug off the ground.

The Securities and Exchange Commission has nabbed another set of traders who allegedly profited off biopharma secrets. This time, their alleged source wasn't a pharma insider, but a former FDA official.